share_log

HC Wainwright & Co. Upgrades Onconova Therapeutics to Buy, Announces $11 Price Target

HC Wainwright & Co. Upgrades Onconova Therapeutics to Buy, Announces $11 Price Target

HC Wainwright & Co.将Onconova Therapeutics升级为买入,宣布目标价为11美元
Benzinga ·  2023/04/21 06:48

HC Wainwright & Co. analyst Joseph Pantginis upgrades Onconova Therapeutics (NASDAQ:ONTX) from Neutral to Buy and announces $11 price target.

HC Wainwright & Co. 分析师约瑟夫·潘吉尼斯将Onconova Therapeutics(纳斯达克股票代码:ONTX)从中性上调至买入,并宣布了11美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发